153 related articles for article (PubMed ID: 16575029)
1. Preemptive use of recombinant activated factor VII: many questions but few answers.
Samama CM
Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
[No Abstract] [Full Text] [Related]
2. Recombinant activated factor VII and the anaesthetist.
Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
4. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
Hardy JF
Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
[No Abstract] [Full Text] [Related]
5. [Use of "NovoSeven" (rFVIIa) hemostatic in patients operated with extracorporeal blood circulation].
Dement'eva II; Sandrikov VA; Charnaia MA; Morozov IuA; Trekova NA; Eremenko AA
Anesteziol Reanimatol; 2004; (5):11-3. PubMed ID: 15573716
[TBL] [Abstract][Full Text] [Related]
6. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
Bui JD; Despotis GD; Trulock EP; Patterson GA; Goodnough LT
J Thorac Cardiovasc Surg; 2002 Oct; 124(4):852-4. PubMed ID: 12324751
[No Abstract] [Full Text] [Related]
7. Successful use of activated recombinant factor VII in traumatic liver injuries in children.
Kulkarni R; Daneshmand A; Guertin S; Fath J; Atwal M; Melvin J; LaFrance S
J Trauma; 2004 Jun; 56(6):1348-52. PubMed ID: 15211149
[No Abstract] [Full Text] [Related]
8. Recombinant activated factor VII in cardiac surgery: a systematic review.
Warren O; Mandal K; Hadjianastassiou V; Knowlton L; Panesar S; John K; Darzi A; Athanasiou T
Ann Thorac Surg; 2007 Feb; 83(2):707-14. PubMed ID: 17258029
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
Stratmann G; Russell IA; Merrick SH
Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
[TBL] [Abstract][Full Text] [Related]
10. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
11. Recombinant factor VIIa is a pan-hemostatic agent?
Aledort LM
Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
[No Abstract] [Full Text] [Related]
12. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII.
Tawfick WA; Tawfik S; Hynes N; Mahendran B; Sultan S
Vascular; 2006; 14(1):32-7. PubMed ID: 16849021
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII and perioperative blood loss.
Williams D; McCarthy R
Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767766
[No Abstract] [Full Text] [Related]
14. Recombinant activated factor VII and perioperative blood loss.
Volk T; von Heymann C; Kox WJ
Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767765
[No Abstract] [Full Text] [Related]
15. [Laboratory monitoring of recombinant factor VIIA effects].
Barkagan ZS; Mamaev AN; Tsyvkina LP; Mamaeva IV
Klin Lab Diagn; 2007 May; (5):23-5. PubMed ID: 17665615
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
Gunaydin B; Ozkose Z; Pezek S
J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
[No Abstract] [Full Text] [Related]
17. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
19. Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
O'Connell N; Chen J; Byrne M; O'Shea E; Smyth H; Smith OP
Br J Haematol; 2002 Mar; 116(3):645-8. PubMed ID: 11849225
[TBL] [Abstract][Full Text] [Related]
20. [Use of activated recombinant factor VII in patients with brain injury or undergoing brain surgery].
Ingelmo Ingelmo I; Rama-Maceiras P; Fàbregas Julià N; Hernández Palazón J
Rev Esp Anestesiol Reanim; 2009; 56(6):339-42. PubMed ID: 19725340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
